The "ITGA7 Gene Myopathy Due to Integrin 7A Deficiency Genetic Test" is a specialized diagnostic examination aimed at identifying mutations in the ITGA7 gene, which can lead to a rare form of myopathy. Myopathy associated with ITGA7 gene mutations is characterized by muscle weakness and reduced muscle mass due to a deficiency in integrin alpha-7, a protein essential for muscle cell structure and function. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.
The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics and research. The procedure involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the ITGA7 gene that are known to cause the condition. This genetic test is crucial for accurate diagnosis, allowing for appropriate management and treatment plans to be developed for affected individuals.
The cost of the ITGA7 Gene Myopathy Due to Integrin 7A Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This cost covers the genetic analysis and a comprehensive report that details the findings. For patients suspected of having this rare form of myopathy, or for those with a family history of the condition, this test provides a valuable tool for confirming the diagnosis and facilitating early intervention strategies.
The AMPD1 gene is pivotal in encoding the enzyme myoadenylate deaminase, which plays a crucial role in muscle metabolism, particularly during strenuous exercise. A deficiency in this enzyme, due to mutations in the AMPD1 gene, can lead to a condition known as myoadenylate deaminase deficiency. This condition is characterized by muscle pain, cramps, and exercise intolerance, making it crucial for individuals experiencing such symptoms to undergo diagnostic testing.
DNA Labs UAE offers a specialized genetic test aimed at diagnosing myoadenylate deaminase deficiency by analyzing the AMPD1 gene for any mutations that could lead to the condition. The test involves collecting a DNA sample from the patient, which is then examined for specific mutations in the AMPD1 gene known to cause the deficiency.
The cost of this genetic test at DNA Labs UAE is 4400 AED. This investment allows for a comprehensive understanding of the individual's genetic predisposition to myoadenylate deaminase deficiency, enabling targeted management and treatment strategies. It's an essential tool for individuals experiencing unexplained muscle fatigue and pain, offering a pathway to a more informed and personalized healthcare approach.
The MICU1 Gene Myopathy with Extrapyramidal Signs Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the MICU1 gene, which are implicated in a rare genetic disorder characterized by muscle weakness (myopathy) and abnormalities in movement control (extrapyramidal signs). This condition falls under a broader category of mitochondrial diseases, given MICU1's role in calcium uptake regulation within the mitochondria, essential for energy production and muscle function.
Priced at 4400 AED, this test offers a critical pathway for individuals exhibiting symptoms related to this disorder to obtain a definitive diagnosis. Through a simple genetic analysis, it enables healthcare providers to tailor treatment plans more effectively, potentially improving the quality of life for affected individuals. The test represents a significant advancement in the field of genetic diagnostics, offering hope and answers to patients and their families navigating the complexities of rare genetic conditions.
The CHKB Gene Muscular Dystrophy Congenital Megaconial Type Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CHKB gene, which are linked to a rare form of muscular dystrophy known as congenital megaconial type. This condition is characterized by muscle weakness, developmental delays, and distinctive enlarged mitochondria (megaconia) in muscle cells, leading to a range of physical and possibly cognitive impairments.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques. By examining the specific genetic makeup of the CHKB gene, specialists can confirm a diagnosis of congenital megaconial muscular dystrophy, allowing for early intervention, personalized treatment plans, and genetic counseling for families.
Given the complexity and rarity of this condition, the CHKB gene test is a crucial resource for individuals exhibiting symptoms or with a family history of muscular dystrophy, providing them with essential information for managing the disease. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing results, contributing significantly to the understanding and treatment of this genetic disorder.
The "DMD Gene Muscular Dystrophy Duchenne Type Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the DMD gene, which is responsible for Duchenne Muscular Dystrophy (DMD). This condition is a severe form of muscular dystrophy that primarily affects boys, leading to muscle weakness and degeneration over time. Early diagnosis through genetic testing can provide valuable information for managing the condition, enabling timely interventions and support.
The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. By analyzing a sample of the patient's DNA, the test identifies specific mutations in the DMD gene that are indicative of Duchenne Muscular Dystrophy. This process involves sophisticated technology and expertise to ensure accurate results.
The cost of the DMD Gene Muscular Dystrophy Duchenne Type Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate nature of genetic testing and the specialized analysis required to pinpoint mutations associated with the condition. While the cost may seem significant, the value of the information gained from this test is immeasurable for affected families, providing them with a clear diagnosis and guiding treatment and management decisions for Duchenne Muscular Dystrophy.
The CAPN3 gene muscular dystrophy limb-girdle type 2A genetic test is a specialized diagnostic procedure designed to identify mutations in the CAPN3 gene, which are responsible for causing limb-girdle muscular dystrophy type 2A (LGMD2A). LGMD2A is a form of muscular dystrophy that primarily affects the muscles around the hips and shoulders, leading to progressive muscle weakness and atrophy. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disease.
The test is conducted by DNA Labs UAE, a leading facility in genetic diagnostics and research. Utilizing advanced genetic sequencing technologies, the laboratory examines the CAPN3 gene for any mutations that are known to cause LGMD2A. This precise genetic testing is crucial for accurate diagnosis, enabling targeted management and treatment strategies for affected individuals. Additionally, it can provide valuable information for family planning and genetic counseling for families with a history of this condition.
The cost of the CAPN3 gene muscular dystrophy limb-girdle type 2A genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers critical insights for the diagnosis and management of LGMD2A, potentially improving the quality of life for those affected by this challenging condition.
The PLEC Gene Muscular Dystrophy Limb-Girdle Type 2Q Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the PLEC gene, which are associated with Limb-Girdle Muscular Dystrophy Type 2Q (LGMD2Q). This condition is a part of a group of genetic muscle diseases known for weakening and wasting away of the limb muscles, particularly around the hips and shoulders (limb-girdle area). The test is crucial for individuals showing symptoms of the disease or those with a family history, as it can confirm the diagnosis and help in managing the condition effectively.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA to look for specific mutations in the PLEC gene that are known to cause LGMD2Q. The process is meticulous and requires a sample of the patient's blood or saliva.
The cost of the PLEC Gene Muscular Dystrophy Limb-Girdle Type 2Q Genetic Test at DNA Labs UAE is 4400 AED. Although the price might seem high, it reflects the sophisticated technology and expertise required to accurately identify mutations in the PLEC gene. For patients and families affected by LGMD2Q, this test offers valuable insights into the condition, enabling informed decisions about treatment and management strategies.
The PABPN1 Gene Muscular Dystrophy Oculopharyngeal Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PABPN1 gene, which are linked to Oculopharyngeal Muscular Dystrophy (OPMD). OPMD is a rare genetic disorder characterized by progressive muscle weakness affecting the eyes (ocular) and throat (pharyngeal), typically manifesting in adulthood. The test plays a crucial role in the early detection and management of the condition, allowing for tailored treatment plans and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze the genetic material for mutations associated with this condition. By opting for this test at DNA Labs UAE, patients gain access to critical information that can significantly impact their quality of life and that of future generations.
The RXYLT1 gene muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A10 genetic test is a specialized diagnostic assessment offered by DNA Labs UAE. This test is designed to identify mutations in the RXYLT1 gene, which are associated with a rare form of muscular dystrophy known as dystroglycanopathy congenital with brain and eye anomalies type A10. This condition is characterized by muscle weakness and wasting, along with severe developmental issues affecting the brain and eyes.
The genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the RXYLT1 gene that may lead to the disease. Early diagnosis through this genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling to affected families.
DNA Labs UAE, a leading provider of genetic testing services in the region, offers this comprehensive test at a cost of 4400 AED. The test is conducted in their state-of-the-art facilities, ensuring high-quality, reliable results. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and future.
The B4GAT1 gene plays a critical role in the development and function of muscles, the brain, and the eyes. Mutations in this gene can lead to Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A13 (MDDGA13), a rare genetic disorder characterized by muscle weakness, developmental delays, and structural abnormalities in the brain and eyes. To diagnose this condition, genetic testing is essential.
DNA Labs UAE offers a specialized genetic test for MDDGA13, focusing on identifying mutations in the B4GAT1 gene. This test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment options. The test is available for a cost of 4400 AED. Conducting this test can provide vital information for affected individuals and their families, enabling them to make informed decisions about their healthcare and manage the condition more effectively.
